Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joseph A. Tyndall
2 Sep 2026
Director
Sold on a plan
3,500
$49.70
$173.94K
Kathy Johnson Weiler
7 Aug 2026
Director
Sold on a plan
14,150
$45.30
$640.97K
William P. Mr. Burke
22 Oct 2025
Director
Sold on a plan
1,457
$18.02
$26.25K
William P. Mr. Burke
3 Oct 2025
Director
Sold on a plan
14,571
$18.21
$265.28K
William P. Mr. Burke
3 Oct 2025
Director
Sold on a plan indirect
7,600
$18.21
$138.37K
William P. Mr. Burke
2 Oct 2025
Director
Sold on a plan
7,620
$18.01
$137.20K
William P. Mr. Burke
2 Oct 2025
Director
Sold on a plan indirect
2,400
$18.01
$43.22K

What was left out

Form 4 filings counted 472
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 24 Sep 2007